Thrombembolic Complications of Sepsis and Their Pharmacological Prophylaxis
Authors:
Z. Zenáhlíková 1; J. Výborný 2; Z. Uchytil 2; Z. Krška 2; J. Mazoch 1; I. Malíková 1; J. Kvasnička 1
Authors‘ workplace:
Trombotické centrum a Centrální hematologické laboratoře VFN, Praha
1; 1. chirurgická klinika VFN, Praha
2
Published in:
Čas. Lék. čes. 2007; 146: 597-602
Category:
Review Article
Overview
Patients with severe sepsis are at increased risk for developing thrombembolic phenomena. This article aims to clarify the association between systemic inflammation activation and coagulation, pathogenesis of coagulation abnormalities during severe sepsis. The article reviews incidence and deep venous thrombosis risk factors among these patients and summarizes recent evidence-based guidelines for deep venous thrombosis prophylaxis.
Key words:
sepsis, inflammation, venous thromboembolism.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- Milestones of Cardiovascular Therapy. IV. Reserpine
- Clostridial Sepsis and Gas Gangrene of the Abdominal Wall After Cholecystectomy
- Use of Capillary Electrophoresis in the Clinical Research
- Ten Years Since the Successful Introduction of the First Monoclonal Antibody (Rituximab) into the Therapy of Lymphomas